GSK3B and nonpapillary renal cell carcinoma: These results implied that CTHRC1 may facilitate the PI3K/AKT/GSK3β signaling pathway, thereby promoting the EMT in ccRCC and contributing to the progression of ccRCC (Fig. 1T).